NCT05761093招募中不适用
A Study to Evaluate Patient and Physician Benefit/ Risk Preferences for Treatment of Metastatic Prostate Cancer (mPC) in Hong Kong: a Discrete Choice Experiment
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 入组人数
- 306
- 试验地点
- 1
- 主要终点
- Patient preferences for treatment attributes in prostate cancer from different stages of disease
研究概览
简要总结
The objective of this study is to examine the preference weightings in term of risk/ benefit attributes of treatment in physician and prostate cancer patients from different stages of disease.
研究设计
- 研究类型
- Observational
- 观察模型
- Case Crossover
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- Male
- 接受健康志愿者
- 否
入选标准
- •aged 18 years or older,
- •diagnosis of metastatic prostate cancer within 5 years,
- •able to read and write,
- •accepting and signing the informed consent
排除标准
- •if patients are unable to complete the survey by themselves due to physical or psychological reasons,
- •deemed ineligible by treating physicians if patients are unable to complete the survey by themselves due to physical or psychological reasons,
- •deemed ineligible by treating physicians
结局指标
主要结局
Patient preferences for treatment attributes in prostate cancer from different stages of disease
时间窗: 15 minutes (Once through survey)
Derived from discrete choice experiment
The Preference weighting from Physicians involved in the treatment of prostate cancer in term of risk/benefit attributes of treatment.
时间窗: 15 minutes (Once through survey)
Derived from discrete choice experiment.
次要结局
- To examine their willingness of trading off survival with improving QOL(15 minutes (Once through survey)
- To examine the status of comorbidities on preference weighing(15 minutes (Once through survey))
- To examine the effect of socio-economic status on preference weighing(15 minutes (Once through survey))
研究者
NG Chi Fai
Professor
Chinese University of Hong Kong
研究点 (1)
Loading locations...
相似试验
已完成
不适用
Survey Based Discrete Choice Experiment Study in Prostate Cancer (DECIDER) StudyMetastatic Hormone-sensitive Prostate CancerProstate CancerNCT05381311Astellas Pharma Global Development, Inc.1,020
Unknown
不适用
Willingness to Pay for Patient-centred CareWillingness-to-payPatient-centrednessNCT01834313A.G. Huppelschoten600
已完成
不适用
Patient and Physician Preference Study in Resectable, Non-small Cell Lung Cancer TreatmentsNon-small Cell Lung Cancer (NSCLC)NCT06448793Bristol-Myers Squibb650
已完成
不适用
Patient and Family Decision Making in the Palliative Care SettingAdvanced CancerNCT00682994M.D. Anderson Cancer Center780
已完成
不适用
A Study of Preferences for the First-Line Treatment of Advanced/Metastatic Non-Small Cell Lung CancerCarcinoma, Non-Small-Cell LungNCT05250817Bristol-Myers Squibb501